This inventor holds 2 USPTO granted patents. Top assignees: Gilead Sciences, Inc., The Endowment for Research in Human Biology, Inc.. Active years: 2011-2012.
Company Filing History:
2 out of 946 
1 out of 10 Years Active: 2011-2012
Title: Guoxin Tao: Innovator in ALDH-2 Inhibitors
Introduction
Guoxin Tao is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of addiction treatment through his innovative research and development of ALDH-2 inhibitors. With a total of 2 patents, his work has the potential to impact the lives of many individuals struggling with addiction.
Latest Patents
Guoxin Tao's latest patents include groundbreaking discoveries in the treatment of addiction. One of his notable inventions involves novel isoflavone derivatives that serve as ALDH-2 inhibitors. These compounds are designed to treat mammals for dependence on drugs of addiction, including dopamine-producing agents such as cocaine, morphine, amphetamines, nicotine, and alcohol. Additionally, he has developed quinazolinone derivatives that also function as ALDH-2 inhibitors, showcasing his commitment to advancing therapeutic options in this critical area.
Career Highlights
Throughout his career, Guoxin Tao has worked with prominent organizations, including Gilead Sciences, Inc. and The Endowment for Research in Human Biology, Inc. His experience in these institutions has allowed him to refine his expertise and contribute to significant advancements in medical research.
Collaborations
Guoxin Tao has collaborated with esteemed colleagues, including Matthew Abelman and Michael Organ. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Guoxin Tao's contributions to the field of addiction treatment through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for new therapeutic approaches that can help individuals overcome addiction.